Back
Return
Biography

Prof. Gabriel Salazar Tortolero

Head of neurological deparment Hospital de Terrassa, Barcelona Spain
International University of catalonia
Associate Professor for
neurology


Email: gsalaz64@gmail.com (preferred), gsalazar@cst.cat


Qualifications

1996 Neurologist, Hospital San Carlos Madrid, Spain

1999 Post-Doctoral Fellowship in Movement Disorders, Hospital Clínic, Barcelona, Spain

1998 Fellowship in clinical and neurophisiology of Movement, Hospital Clínic, Barcelona, Spain


Research Fields

QEEG and neurodegenerative diseases
Parkinsonism and neurophysiology
Parkinson´s disease and other mov disorders surgery
Headache and urgency
Epilepsy in urgency

Publications (selected)

  1. G. Salazar; et al. "Post infectious Opsoclinus-Myoclonus syndrome in a Cov-2 infected patient". EC Neurology, 12.9 (2020) 99-101
  2. G.Salazar(www.barcelonaparkinson.com) . J. Badia ( Teracat) Application for self evaluation in Parkinson's disease patients: MiParkinson ( Android and IOS).
  3. Gabriel Salazar, Marta Fragoso, Jonatan Martí, Noelia Martín, Rosó Bernal. Continuous Apomorphine Infusion in Patients with Advanced Parkinson’s Disease with Varying Degrees of functional impairment. Journal of Behavioral and Brain Science, 2016, 6,393-403.http://www.scirp.org/journal/jbb
  4. G. Salazar. M.Fragoso. M. Font. Apomorphine in pump for advaced PD patients with different functional disability. Neurologia April 2016.
  5. Francesc Vallderiola,1,2 Yaroslau Compta,1,2 Javier Aparicio,3 Jaume Tarradellas,4 Gabriel Salazar,5 et al.Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson’s Disease.Parkinson’s Disease.Volume 2015 (2015), Article ID 475630, 6
  6. Salazar G, Fragoso M, Rey A, Sánchez L, Navarro MG (2014) IncobotulinumtoxinA (Xeomin®) and OnabotulinumtoxinA (Botox®) for Chronic Migraine Headache: Experience with Higher Doses and Changes to the Injection Technique. J Neurol Disord 2:192. doi: 10.4172/2329-6895.100019.
  7. Salazar G, Fragoso M and Rey A. Lower Body Parkinsonism Patients: Increased Blood Flow in Posterior Cerebral Arteries. Austin J Neurol Disord Epilepsy. 2014; 1(2): 1008.
  8. Salazar G, Fragoso M, Espanol G, Estevez M, Rey A (2015) EEG Findings in Diffuse Lewy Body Disease and Parkinson ́S Disease with Dementia. Brain Disord Ther 4: 156. doi:10.4172/2168-975X.10001
  9. Salazar G. Neuropsychiatric symptoms in Lewy body diffuse disease: a case report. Neurologia 26:499 (2011)
  10. Oromandibular dystonia secondary to radiotherapy. Peripheral injuries triggering thalamic disruption?: A case report. G. Salazar et al. / Basal Ganglia 1 (2011) 235–236
  11. Metoclopramide as a painkiller in acute migraine attacks: CNS drugs and therapy : Recent Patents on CNS Drug Discovery, Volume 6, Number 2, May 2011 , pp. 141-145(5)
  12. Ocullo-Jaw-Lingual synkinesia in PD, MSA and normal subjects. Clinical neutro physiology 121 (2010) 94-97
  13. Amnesia global secundaria a un hematoma espontáneo del cuerpo calloso: A propósito de un caso. Med clin (Barc).2009. May 7
  14. Metoclopramida como analgesico en la cefalea migrañosa intensa en urgencias., Rev. Neurol 2008, 47 (10) 506-508
  15. Baclofeno intratecal en la Distonia generalizada secundaria a una Hipoxia cerebral. Rev. Neurol 2008; 47 (I) pag.53
  16. Eficacia y Tolerancia del Piribedil como terapia adjunta a la l-dopa en Pacientes con enf. De Parkinson: Rev Neurol. 2004 Apr 16-30; 38(8):715-9
  17. Postural and Action Myoclonus in Patients with Parkinsonian Type Multi System Atrophy. Mov. Dis. Vol. 15 n 1, 2000, pp 77-83.
  18. Bladder dysfunction in progressive supranuclear palsy and other parkinsonian disorders. European neurological societies June1997 en Rhodas-Grece.
  19. Postural and action myoclonus in patients with parkinsonian type multiple system atrophy Mov. Dis.Volume 15 Issue 1, Pages 77-83